Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

February 11, 2019 08:01 ET | Source: Eton Pharmaceuticals

Eton Pharmaceuticals Enters Into License Agreement for Two Branded Hospital Product Candidates

Transaction adds an additional potential 2019 product launch to Eton’s pipeline ET-202 NDA was submitted in December 2018; PDUFA date expected to be in Q4 2019 ET-203 NDA expected to be submitted by...
January 24, 2019 16:10 ET | Source: Eton Pharmaceuticals

Eton Pharmaceuticals Announces Licensing of Oral Liquid Product Candidate ET-104

DEER PARK, Ill., Jan. 24, 2019 (GLOBE NEWSWIRE) -- Eton Pharmaceuticals, Inc. (NASDAQ: ETON), a specialty pharmaceutical company focused on developing and commercializing innovative drug products,...
December 20, 2018 06:30 ET | Source: Eton Pharmaceuticals

Eton Pharmaceuticals Reports Third Quarter Results and Business Update

Licensed High-Value Injectable Product Candidate Successfully Completed Initial Public Offering DEER PARK, Ill., Dec. 20, 2018 (GLOBE NEWSWIRE) -- Eton Pharmaceuticals, Inc. (NASDAQ: ETON), a...
November 12, 2018 16:52 ET | Source: Eton Pharmaceuticals

Eton Pharmaceuticals Announces Pricing of Initial Public Offering

DEER PARK, Ill., Nov. 12, 2018 (GLOBE NEWSWIRE) -- Eton Pharmaceuticals, Inc (NASDAQ: ETON), a specialty pharmaceutical company focused on developing and commercializing innovative drug products,...